Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(3)

Detailed Status

Withdrawn2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

terminated125%
withdrawn250%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
terminatednot_applicable

Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults

NCT04725071
completednot_applicable

Nutritional and Functional Changes in Heart Failure and COPD

NCT01787682
withdrawnphase_2

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

NCT03628144
withdrawnnot_applicable

Chronic Kidney Disease in Relation to Alterations in Protein and Amino Acid Metabolism and Function

NCT01890811

Clinical Trials (4)

Showing 4 of 4 trials
NCT04725071Not Applicable

Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults

Terminated
NCT01787682Not Applicable

Nutritional and Functional Changes in Heart Failure and COPD

Completed
NCT03628144Phase 2

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

Withdrawn
NCT01890811Not Applicable

Chronic Kidney Disease in Relation to Alterations in Protein and Amino Acid Metabolism and Function

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4